CompuGroup Medical SE & Co. KGaA

CMPUYOTCHealthcare

$23.00

$-1.80(-7.26%)

Market Cap$1.2B

P/E Ratio—

52W High$27.33

52W Low$14.485

Avg Volume8

Open$23.00

Beta0.82

Overview

CompuGroup Medical SE & Co. KGaA (CMPUY) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CMPUY · free cash flow · updated Jun 9, 2026

Core FCF metrics

CMPUY · FCF · TTM · margin & CAGR

Free cash flow was $65.7M for FY2024 (fiscal year ending 2024-12-31), down 41.2% year-over-year The FCF margin was 5.7%. Five-year CAGR stands at -0.3%.

FY2024 Free Cash Flow$65.7M▼ -41.2% YoY

Trailing 12M (TTM)$84.6Mtrailing 4 quarters sum

FCF Margin5.7%$65.7M ÷ revenue

3-Year CAGR-9.2%FY2021 → FY2024

5-Year CAGR-0.3%FY2019 → FY2024

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CMPUY · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest$128.9M(63M)$65.7M▼ 41.2%5.7%

FY2023$179.5M(68M)$111.7M▲ +74.5%9.4%

FY2022$145.0M(81M)$64.0M▼ 27.1%5.7%

FY2021$165.3M(77M)$87.8M▼ 6.8%8.6%

FY2020$149.9M(56M)$94.2M▲ +41.1%11.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CMPUY · P/FCF · FCF yield · FCF per share

CompuGroup Medical SE & Co. KGaA (CMPUY) trades at a FCF yield of 7.53% and a price-to-free-cash-flow ratio of 14.0x. FCF per share stands at $1.64, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

7.53%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.64

TTM FCF ÷ Shares Outstanding

Price / FCF

x14.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x21.3

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

CMPUY · cash flow statement · operating / investing / financing

For FY2024, CompuGroup Medical SE & Co. KGaA generated $128.9M in operating cash flow and spent 63M in capital expenditures, yielding $65.7M in free cash flow.

Operating Activities

+$128.9M

Cash from core business operations

2024-12-31

Investing Activities

−$105.3M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

+$18.8M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF ($128.9M) − |CapEx| (63M) = FCF ($65.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CMPUY vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CompuGroup Medical SE & Co. KGaAYOU

CMPUY

$65.7M-41.2%5.7%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CompuGroup Medical SE & Co. KGaA (CMPUY) reported free cash flow of $65.7M for FY2024 (fiscal year ending 2024-12-31), down 41.2% year-over-year. The FCF margin was 5.7%.

Based on available data, CompuGroup Medical SE & Co. KGaA has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $111.7M in FY2023. The 5-year CAGR stands at -0.3%.

CompuGroup Medical SE & Co. KGaA's FCF yield is 7.53% and price-to-FCF ratio is 14.0x for FY2024, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CMPUY free cash flow · 8 questions

CompuGroup Medical SE & Co. KGaA free cash flow was $65.7M for FY2024, down 41.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $84.6M.

CMPUY free cash flowCMPUY FCFCMPUY FCF 2024CMPUY free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CompuGroup Medical SE & Co. KGaA · CompuGroup Medical SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026